
Ceflect T 500mg/62.5mg Injection
Marketer
Intellect Lifescience
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Ceflect T 500mg/62.5mg Injection
Ceflect T 500mg/62.5mg injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism involves inhibiting microbial growth, thereby halting infection progression. Administration must be solely under a physician's guidance; consistent adherence to the prescribed schedule is crucial. Complete the full course of treatment, even with symptom improvement, as premature cessation can compromise its effectiveness. Typical mild side effects include nausea, vomiting, diarrhea, and upset stomach; severe reactions necessitate immediate medical attention. Allergic responses (skin rashes, itching, swelling, respiratory distress) demand urgent medical care. Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While it generally doesn't affect driving ability, refrain from driving if drowsiness or dizziness occurs. Sufficient rest, a nutritious diet, and ample hydration promote faster recovery. Your doctor may order blood tests and other diagnostics to monitor treatment efficacy.
Uses of Ceflect T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Ceflect T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceflect T 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceflect T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ceflect T 500mg/62.5mg Injection works:
Ceftriaxone and Tazobactum, combined as Ceflect T 500mg/62.5mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, a beta-lactamase inhibitor, complements Ceftriaxone by counteracting bacterial resistance mechanisms, thus maximizing its effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ceflect T 500mg/62.5mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceflect T 500mg/62.5mg is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
The administration of Ceflect T 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Ceflect T 500mg/62.5mg Injection may induce drowsiness, blurred vision, or dizziness. Refrain from driving if such effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Ceflect T 500mg/62.5mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Ceflect T 500mg/62.5mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Ceflect T 500mg/62.5mg Injection is not advised for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Ceflect T 500mg/62.5mg Injection :
Omitting a scheduled dose of Ceflect T 500mg/62.5mg Injection warrants immediate physician consultation.
Facts to Know About Ceflect T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
